Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Revenue Multiple | 1,2x - 1,4x | 1,3x |
| Selected Fwd Revenue Multiple | 1,2x - 1,3x | 1,2x |
| Fair Value | ₩8.057 - ₩8.805 | ₩8.431 |
| Upside | 26,9% - 38,7% | 32,8% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| INSAN Inc. | A277410 | KOSDAQ:A277410 |
| Genic Co., Ltd. | A123330 | KOSDAQ:A123330 |
| Icure Pharmaceutical Incorporation | A175250 | KOSDAQ:A175250 |
| Tonymoly Co., Ltd | A214420 | KOSE:A214420 |
| Outin Futures Co., Ltd | A227610 | KOSDAQ:A227610 |
| Hankook Cosmetics Co., Ltd. | A123690 | KOSE:A123690 |
| Select LTM Revenue Multiple | ||||||||
| Benchmark Companies | ||||||||
| A277410 | A123330 | A175250 | A214420 | A227610 | A123690 | |||
| KOSDAQ:A277410 | KOSDAQ:A123330 | KOSDAQ:A175250 | KOSE:A214420 | KOSDAQ:A227610 | KOSE:A123690 | |||
| Historical Revenue Growth | ||||||||
| 5Y CAGR | 4.7% | 3.0% | 11.3% | 0.6% | -8.5% | -12.5% | ||
| 3Y CAGR | -5.3% | 9.1% | -14.3% | 15.6% | -7.6% | 2.8% | ||
| Latest Twelve Months | -12.9% | 77.8% | 1.7% | 17.1% | 6.1% | 17.9% | ||
| Historical EBIT Profit Margin | ||||||||
| 5 Year Average Margin | 15.5% | -5.9% | -35.0% | -6.0% | -21.0% | -6.1% | ||
| Prior Fiscal Year | 15.4% | -14.3% | -45.6% | 6.4% | -1.0% | 3.7% | ||
| Latest Fiscal Year | 2.5% | 12.1% | -48.8% | 6.9% | -9.9% | 4.0% | ||
| Latest Twelve Months | 2.5% | 12.1% | -44.0% | 6.9% | -9.9% | 4.0% | ||
| Current Trading Multiples | ||||||||
| EV / LTM Revenue | 1.94x | 3.61x | 1.17x | 1.23x | 1.22x | 0.98x | ||
| EV / LTM EBIT | 77.6x | 29.9x | -2.7x | 17.9x | -12.4x | 24.2x | ||
| Price / LTM Sales | 1.44x | 3.52x | 1.00x | 1.23x | 0.89x | 1.14x | ||
| Low | Mid | High | ||||||
| Benchmark EV / LTM Revenue | 1.17x | 1.23x | 3.61x | |||||
| Historical EV / LTM Revenue | 0.98x | 1.92x | 2.11x | |||||
| Selected EV / LTM Revenue | 1.25x | 1.31x | 1.38x | |||||
| (x) LTM Revenue | 92,788 | 92,788 | 92,788 | |||||
| (=) Implied Enterprise Value | 115,603 | 121,687 | 127,772 | |||||
| (-) Non-shareholder Claims * | 15,166 | 15,166 | 15,166 | |||||
| (=) Equity Value | 130,769 | 136,853 | 142,938 | |||||
| (/) Shares Outstanding | 16.1 | 16.1 | 16.1 | |||||
| Implied Value Range | 8,138.95 | 8,517.63 | 8,896.32 | |||||
| FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 8,138.95 | 8,517.63 | 8,896.32 | 6,350.00 | ||||
| Upside / (Downside) | 28.2% | 34.1% | 40.1% | |||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | A277410 | A123330 | A175250 | A214420 | A227610 | A123690 | |
| Enterprise Value | 62,253 | 174,445 | 68,688 | 211,886 | 40,790 | 86,860 | |
| (+) Cash & Short Term Investments | 12,537 | 1,290 | 22,492 | 24,271 | 8,129 | 16,336 | |
| (+) Investments & Other | 2,180 | 0 | 8,091 | 48,165 | 1,611 | 5,437 | |
| (-) Debt | (30,882) | (5,940) | (37,728) | (64,780) | (23,526) | (6,545) | |
| (-) Other Liabilities | (329) | 0 | (696) | (6,810) | 2,312 | (63) | |
| (-) Preferred Stock | 0 | 0 | (2,624) | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 45,760 | 169,796 | 58,222 | 212,734 | 29,316 | 102,026 | |
| (/) Shares Outstanding | 37.7 | 7.8 | 37.4 | 23.9 | 35.4 | 16.1 | |
| Implied Stock Price | 1,214.00 | 21,700.00 | 1,558.00 | 8,900.00 | 827.00 | 6,350.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 1,214.00 | 21,700.00 | 1,558.00 | 8,900.00 | 827.00 | 6,350.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |